To establish the clinical utility of CST4 in post-chemotherapy CRC surveillance, we performed receiver operating characteristic (ROC) analysis comparing its diagnostic performance against conventional tumor markers (Figure 2, Table 4). This evidence concerns the gene CST4 and neoplasm.